Wunderlich Capital Managemnt Astrazeneca PLC Transaction History
Wunderlich Capital Managemnt
- $212 Million
- Q2 2024
A detailed history of Wunderlich Capital Managemnt transactions in Astrazeneca PLC stock. As of the latest transaction made, Wunderlich Capital Managemnt holds 4,350 shares of AZN stock, worth $285,490. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,350
Previous 3,788
14.84%
Holding current value
$285,490
Previous $256,000
32.42%
% of portfolio
0.16%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...